ID
23246
Descripción
Responsible Party: Dominik Bettinger, investigator, University Hospital Freiburg ClinicalTrials.gov Identifier: NCT01360255 History of Changes Other Study ID Numbers: HCC2 DRKS00000812 ( Registry Identifier: German Clinical Trials Register ) Study First Received: May 9, 2011 Last Updated: December 14, 2011 AFP- L3% and DCP as Tumor Markers in Patients With Hepatocellular Carcinoma (HCC) Treated With Transarterial Chemoembolisation (TACE) ODM derived from: https://clinicaltrials.gov/ct2/show/NCT01360255
Link
https://clinicaltrials.gov/ct2/show/NCT01360255
Palabras clave
Versiones (1)
- 2017-06-30 2017-06-30 -
Subido en
30 juni 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Hepatocellular Carcinoma DRKS00000812 NCT01360255 DRKS00000812
Eligibility Hepatocellular Carcinoma NCT01360255 DRKS00000812
- StudyEvent: ODM
Descripción
Exclusion Criteria
Alias
- UMLS CUI-1
- C0680251
Descripción
Control Group
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0009932
Descripción
Liver tumor of unknown origin
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C2239176
- UMLS CUI [1,2]
- C0346426
Descripción
Other liver tumors
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0205394
- UMLS CUI [1,2]
- C2239176
Descripción
Contraindication to TACE
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C3539919
- UMLS CUI [1,2]
- C1301624
Similar models
Eligibility Hepatocellular Carcinoma NCT01360255 DRKS00000812
- StudyEvent: ODM
C1301732 (UMLS CUI [1,2])
C0346426 (UMLS CUI [1,2])
C2239176 (UMLS CUI [1,2])
C1301624 (UMLS CUI [1,2])